Treatment of hepatitis C using histone deacetylase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9763901
SERIAL NO

15370275

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to method of treatment of hepatitis C using bufexamac or a derivative thereof. The methods of the present invention can be used in patients with hepatitis C administering bufexamac or a derivative thereof in combination with one or more anti-hepatitis C drugs.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CIPLA LTDINDIA MUMBAI PA REHL GANBOTELAAO GA WHEN PAIMAGE PENINSULA BUSINESS PARK BUILDING PULA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Joshi, Kalpana Maharashtra, IN 55 139
Malhotra, Geena Mumbai, IN 171 915

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 19, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 19, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00